Month 2 Summary: You Survived Weight loss: 4-7 pounds this month (8-11 pounds total, 4-5% of starting weight) Peak nausea: Weeks 6-7 rated moderate to severe by 65% of people Side effects: Highest throughout entire 48-week treatment Discontinuation rate: 15-18% stop during month 2 (highest attrition period) Psychological state: Tested resolve, questioned decisions, but persisted Key achievement: Proved you can handle difficult periods
Dihexa is more experimental the effects reported are deeper and potentially more significant, but the risk profile is less understood
Understanding the mechanisms behind glial diversity and dysfunction, especially in the context of innate immunity signaling (e.g., cGAS-STING) in mitochondria, phase separation in cellular lipid, and senolytics progress, may unlock novel therapeutic avenues
66.3% for semaglutide monotherapy
Both oral and injectable BPC-157 are available through PeptidesThailand.com, and each serves a different clinical purpose
Hydration: We always say "Hydrate or Die" for a reason
